Lit Matters 1: Unpacking IV Antihypertensives in Neuro Emergencies

Acute blood pressure control in neurovascular emergencies is about reaching target quickly without overshoot that could worsen cerebral ischemia. Across ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, TBI, and hypertensive encephalopathy, current comparative evidence does not identify a single best IV antihypertensive.

IV Antihypertensives in Neuro Emergencies

• Evidence quality limits certainty: The comparative literature is thin and biased: only 10 studies met review criteria, with just 2 randomized trials, so claims of superiority should stay modest.
• Nicardipine over labetalol: Nicardipine generally reached blood pressure goals faster than labetalol and often needed fewer rescue agents, with steadier control than intermittent bolus strategies.
• Clevidipine comparison signals: Clevidipine sometimes trended toward faster control than nicardipine, but the differences were not statistically convincing and time in goal range looked similar.
• Nitroprusside practical concern: Nitroprusside remains the least attractive neurocritical option because of concern for increased ICP and reduced cerebral perfusion pressure, despite inconsistent mortality data.
• Titratable drip advantage: Blood pressure variability is easier to manage with titratable infusions like nicardipine or clevidipine than with bolus labetalol. We get into the bedside why in the episode.
• Choose familiarity over theory: No agent clearly wins on hard outcomes, so the practical move is to standardize around a drug your team knows well; nicardipine is a common favorite for cost and ease.